United States
    Diagnostics & Testing >  Infectious Disease Testing

    Infectious Disease Testing

    OraSure Technologies is a global leader in infectious disease diagnostics, and our unique infectious disease assays for HIV, HCV, Ebola, and influenza provide accurate and easy-to-administer testing methods to help healthcare practitioners easily identify infected people.

    OraQuick® HCV Rapid Antibody Test

    OraQuick® HCV Rapid Antibody Test

    The first and only FDA approved and CLIA Waived point of care test for HCV that is also CE Marked. Our simple platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes.

    View OraQuick HCV Rapid Antibody Test »
    OraQuick® Self-Test

    OraQuick® HIV Self-Test

    The OraQuick® HIV Self-Test (HIVST) is a point-of-care rapid antibody test. It detects antibodies for both HIV-1 and HIV-2, enabling individuals to find out their HIV status with a simple oral swab in as little as 20 minutes. The simplicity of the product makes it ideal for testing in a range of locations, including in the privacy of one’s home, at the pharmacy, or at community-based testing events. This test is available for use in select geographic locations outside of the US.

    View OraQuick HIV Self-Test »
    Oraquick ADVANCE® HIV-1/2 Rapid Antibody Test

    Oraquick ADVANCE® HIV-1/2 Rapid Antibody Test

    The OraQuick ADVANCE® Rapid HIV‑1/2 Antibody Test is FDA‑approved for use with oral fluid, fingerstick or venous whole blood and plasma and delivers results with laboratory accuracy in 20 minutes. CDC guidelines call for routine testing in all healthcare settings to identify all HIV positive people and connect them to care. This simple test is ideal for screening programs in public health and outreach settings, emergency departments, labor and delivery, laboratories and physician offices.

    View Oraquick ADVANCE HIV-1/2 Rapid Antibody Test »
    OraQuick® In-Home HIV Test

    OraQuick® In-Home HIV Test

    The OraQuick® In-Home HIV Test is the first and only oral fluid rapid over‑the‑counter (OTC) HIV test approved in the U.S. It can detect antibodies to both HIV‑1 and HIV‑2 with an oral swab, providing a confidential in‑home testing option with results in as little as 20 minutes. The test kit comes with extensive resources and support, including access to a "live" toll‑free customer support center and comprehensive consumer website.

    View OraQuick In-Home HIV Test »
    OraQuick® Ebola Rapid Antigen Test

    OraQuick® Ebola Rapid Antigen Test

    The OraQuick® Ebola Rapid Antigen Test is designed to detect viral antigens in fingerstick and venous whole blood from patients presenting with signs and symptoms of Ebola infection in conjunction with epidemiological risk factors. It is also intended for use with cadaveric oral fluid collected from recently deceased individuals with epidemiological risk factors who are suspected to have died of EVD.

    View OraQuick Ebola Rapid Antigen Test »
    OraSure QuickFlu™ Rapid Flu A+B Test

    OraSure QuickFlu Rapid Flu A+B Test

    An FDA-approvedin vitro rapid qualitative test for the detection and differentiation of influenza type A and type B. An easy nasal swab procedure provides accurate results in as little as 10 minutes.

    View OraSure QuickFlu Rapid Flu A+B Test »
    OraSure® HIV-1 Oral Specimen Collection Device

    OraSure® HIV-1 Oral Specimen Collection Device

    OraSure® HIV-1 Oral Specimen Collection Device collects oral fluid, which contains antibodies. The simple 2-5 minute collection procedure is ideal for insurance testing and other non-medical settings. The OraSure® device is placed into a preservative and shipped to a lab where the sample will be screened for HIV-1 antibodies.

    View OraSure HIV-1 Oral Specimen Collection Device »
    UrSure Logo


    UrSure, a wholly-owned subsidiary of OraSure, offers diagnostic tests that measure adherence to HIV medications, including pre-exposure prophylaxis or PrEP, the daily medication to prevent HIV. This includes laboratory-based tests that can measure levels of the medication in a patient’s urine or blood, as well as several additional point of care products in development.

    Continue to »